JP2005526061A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005526061A5 JP2005526061A5 JP2003574169A JP2003574169A JP2005526061A5 JP 2005526061 A5 JP2005526061 A5 JP 2005526061A5 JP 2003574169 A JP2003574169 A JP 2003574169A JP 2003574169 A JP2003574169 A JP 2003574169A JP 2005526061 A5 JP2005526061 A5 JP 2005526061A5
- Authority
- JP
- Japan
- Prior art keywords
- release
- active ingredient
- area
- treatment system
- incisions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000004480 active ingredient Substances 0.000 claims 4
- 210000004940 Nucleus Anatomy 0.000 claims 2
- 239000007864 aqueous solution Substances 0.000 claims 2
- 239000011248 coating agent Substances 0.000 claims 2
- 238000000576 coating method Methods 0.000 claims 2
- 239000007888 film coating Substances 0.000 claims 1
- 238000009501 film coating Methods 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 230000000051 modifying Effects 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 230000001225 therapeutic Effects 0.000 claims 1
Claims (3)
- 水性溶液に不溶解性および不透過性の、ポリマー材料のフィルムコーティングにより完全にコートされた活性成分を含む核を含むことにより特徴づけられ、望ましい活性成分の放出の速度および進行の機能として予め決定された寸法および形状の面積を決める一つ以上の切り込みが作られ、該放出は、治療システムが水性溶液に接触するときに取り除かれる切り込みにより範囲が定められるコーティングフィルムの表面の下に存在する核のエリアから発生するものである、錠剤の形態における一つ以上の活性成分の経口投与のための治療システム。
- 核が、活性成分の放出を調節することができる一つ以上のポリマー物質を含む、請求項1記載の治療システム。
- 切り込みが、コーティングフィルムの表面全体の2%〜80%の間で構成される寸法の面積を定義する、請求項1記載の治療システム。
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2002MI000515A ITMI20020515A1 (it) | 2002-03-12 | 2002-03-12 | Sistema per il rilasco controllato di uno o piu' principi attivi |
| PCT/EP2003/002537 WO2003075894A1 (en) | 2002-03-12 | 2003-03-12 | A system for the controlled release of active ingredients |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005526061A JP2005526061A (ja) | 2005-09-02 |
| JP2005526061A5 true JP2005526061A5 (ja) | 2006-04-20 |
Family
ID=11449491
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003574169A Pending JP2005526061A (ja) | 2002-03-12 | 2003-03-12 | 活性成分の放出を制御するためのシステム |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20050163845A1 (ja) |
| EP (1) | EP1482913A1 (ja) |
| JP (1) | JP2005526061A (ja) |
| CN (1) | CN1649570A (ja) |
| AU (1) | AU2003214121A1 (ja) |
| CA (1) | CA2478514A1 (ja) |
| IT (1) | ITMI20020515A1 (ja) |
| WO (1) | WO2003075894A1 (ja) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1295926A1 (en) | 2001-09-19 | 2003-03-26 | ExxonMobil Chemical Patents Inc. | Components for adhesive compositions and process for manufacture |
| GB0203296D0 (en) * | 2002-02-12 | 2002-03-27 | Glaxo Group Ltd | Novel composition |
| US8637512B2 (en) | 2002-07-29 | 2014-01-28 | Glaxo Group Limited | Formulations and method of treatment |
| PL1663175T3 (pl) * | 2003-09-19 | 2012-09-28 | Sun Pharma Advanced Res Co Ltd | Doustny system podawania leku |
| US10226428B2 (en) | 2003-09-19 | 2019-03-12 | Sun Pharma Advanced Research Company Ltd. | Oral drug delivery system |
| US10213387B2 (en) | 2003-09-19 | 2019-02-26 | Sun Pharma Advanced Research Company Ltd. | Oral drug delivery system |
| CA2592605C (en) | 2004-12-27 | 2010-12-07 | Eisai R&D Management Co., Ltd. | Method for stabilizing anti-dementia drug |
| WO2009122431A2 (en) * | 2008-02-15 | 2009-10-08 | Sun Pharma Advanced Research Company Ltd., | Oral controlled release tablet |
| WO2009146537A1 (en) * | 2008-06-02 | 2009-12-10 | Pharmascience Inc. | Multilayer control-release drug delivery system |
| EP2163240A1 (en) | 2008-09-12 | 2010-03-17 | Universita' Degli Studi Di Genova | A method for the production of bioadhesive compact matrices |
| FR2966731B1 (fr) * | 2010-11-03 | 2013-04-26 | Sanofi Aventis | Forme pharmaceutique solide marquee et son procede de fabrication par marquage laser |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1478759A (en) * | 1974-11-18 | 1977-07-06 | Alza Corp | Process for forming outlet passageways in pills using a laser |
| US4077407A (en) * | 1975-11-24 | 1978-03-07 | Alza Corporation | Osmotic devices having composite walls |
| US4503030A (en) * | 1983-06-06 | 1985-03-05 | Alza Corporation | Device for delivering drug to certain pH environments |
| US4792448A (en) * | 1987-06-11 | 1988-12-20 | Pfizer Inc. | Generic zero order controlled drug delivery system |
| US5256440A (en) * | 1992-06-22 | 1993-10-26 | Merck & Co., Inc. | Process for producing a tablet core aperture |
| US5376771A (en) * | 1992-07-07 | 1994-12-27 | Merck & Co., Inc. | High speed process for preparing orifices in pharmaceutical dosage forms |
| IT1264517B1 (it) * | 1993-05-31 | 1996-09-24 | Ekita Investments Nv | Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati |
| US5658474A (en) * | 1994-12-16 | 1997-08-19 | Alza Corporation | Method and apparatus for forming dispenser delivery ports |
| CN1158071C (zh) * | 1997-05-30 | 2004-07-21 | 渗透有限公司 | 多层渗透装置 |
| PL192273B1 (pl) * | 1997-09-25 | 2006-09-29 | Bayer Ag | Preparat środka leczniczego w postaci pastylki o kontrolowanej dyfuzji lub w postaci układu matrycowego, o kontrolowanym uwalnianiu substancji czynnej |
| UA67802C2 (uk) * | 1998-10-23 | 2004-07-15 | Пфайзер Рісьоч Енд Дівелепмент Компані, Н.В./С.А. | Фармацевтична композиція з контрольованим вивільненням інгібітора цгмф фде-5 (варіанти), спосіб її одержання та спосіб лікування еректильної дисфункції |
| SE9804314D0 (sv) * | 1998-12-14 | 1998-12-14 | Astra Ab | New pharmaceutical formulation |
| AU776314B2 (en) * | 1999-07-20 | 2004-09-02 | Merck & Co., Inc. | Sustained release drug dispersion delivery device |
| AR026148A1 (es) * | 2000-01-21 | 2003-01-29 | Osmotica Argentina S A | Dispositivo osmotico con pasaje preformado que aumenta de tamano |
-
2002
- 2002-03-12 IT IT2002MI000515A patent/ITMI20020515A1/it unknown
-
2003
- 2003-03-12 JP JP2003574169A patent/JP2005526061A/ja active Pending
- 2003-03-12 CA CA002478514A patent/CA2478514A1/en not_active Abandoned
- 2003-03-12 AU AU2003214121A patent/AU2003214121A1/en not_active Abandoned
- 2003-03-12 CN CNA03809312XA patent/CN1649570A/zh active Pending
- 2003-03-12 WO PCT/EP2003/002537 patent/WO2003075894A1/en active Application Filing
- 2003-03-12 EP EP03709778A patent/EP1482913A1/en not_active Ceased
- 2003-03-12 US US10/507,345 patent/US20050163845A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY169471A (en) | Controlled release preparation | |
| HK1046244A1 (en) | Controlled release and taste masking oral pharmaceutical compositions. | |
| AP2001002237A0 (en) | Hydrogel-driven drug dosage form. | |
| HUP9904174A2 (hu) | Bőrön át történő adagoláshoz szánt gyógyszerkészítmények | |
| ATE269709T1 (de) | Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff | |
| HUP0203451A2 (hu) | Új, tuberkolózis elleni gyógyszerkészítmények és eljárás előállításukra | |
| CA2414665A1 (en) | Rapidly disintegrating dosage form for releasing active ingredients in the oral cavity or in body cavities | |
| WO2006023286A3 (en) | Controlled release nanoparticle active agent formulation dosage forms and methods | |
| ATE464883T1 (de) | Geschmacksabdeckende formulierung mit einer retardierten wirkstoffformulierung und/oder schnell löslichem cyclodextrin | |
| JP2003509343A5 (ja) | ||
| JP2005526061A5 (ja) | ||
| ATE303793T1 (de) | Pharmazeutische komposition für verlängerte/langanhaltende freisetzung eines therapeutisch aktiven wirkstoffes | |
| WO2005027843A3 (en) | Chronotherapeutic dosage forms | |
| MY130332A (en) | Pharmaceutical formulation comprising iota-carrageenan and at least one neutral gelling polymer | |
| JP2007501248A5 (ja) | ||
| AU2357202A (en) | Ion-strength independent sustained release pharmaceutical formulation | |
| NO20055601D0 (no) | Farmasoytisk preparat i form av en hydrogel for transdermal administrasjon av aktive virkestoffer | |
| ATE262893T1 (de) | Darreichungsformen zur behandlung von oralen mykosen | |
| CA2417887A1 (en) | Particulate composition of eletriptan | |
| CA2489140A1 (en) | Dosage form containing pantoprazole as active ingredient | |
| ATE286894T1 (de) | 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen | |
| WO2003075894A8 (en) | A system for the controlled release of active ingredients | |
| JP2002537246A5 (ja) | ||
| JP2002212063A5 (ja) | ||
| DE602004000016D1 (de) | Schnell freisetzende farmazeutische darreichungsform enthaltend polymorphes tibolon |